MARY SMITH: Open Payments
NPI 1598310740 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 34 payments from 21 companies in 2025. Trend: 2023 $1,135 · 2024 $862 · 2025 $749
Food & beverage: $640Education: $109
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $115 |
| Aveo Pharmaceuticals, Inc. | 2 | $107 |
| TerSera Therapeutics LLC | 2 | $67 |
| BeOne Medicines USA, Inc. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Agios Pharmaceuticals, Inc. | 2 | $33 |
| Celgene Corporation | 1 | $31 |
| Deciphera Pharmaceuticals Inc. | 2 | $31 |
| ARRAY BIOPHARMA INC | 1 | $24 |
| Kite Pharma, Inc. | 1 | $23 |
Products named: FOTIVDA, Zoladex, BRUKINSA, IMFINZI, PLUVICTO, CALQUENCE, PYRUKYND, REBLOZYL.
Industry payments across AL — which companies pay providers there.
